Here, we present evidence that tumor-cell enhancer H3K4 mono-methylases MLL3 and MLL4 suppress T cell-mediated cytotoxicity and promote tumor immunosuppression in syngeneic murine models of multiple cancer types. The gene discussed is KMT2D; the disease is neoplasm.